Sandra Calvin - SVP, CHIEF ACCOUNTING OFFICER at Travere Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Chief Accounting Officer
Stock Symbol
TVTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sandra Calvin - trading volume in the past year for Travere Therapeutics, Inc.

Holdings reported by Sandra Calvin for Travere Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 52K $444K $8.53 Feb 1, 2024 Direct
Employee stock option (right to buy) 25K Jan 31, 2024 Direct Common Stock

Transactions reported by Sandra Calvin for Travere Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.